Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

Deal backed by Achieve Acceleration Loans brings total securitization volume of Achieve assets to over $6.4 billion The securitization, ACHV ABS Trust 2024-3AL, includes five classes of rated notes ...

Achieve Life Sciences has appointed Benjamin Halladay as Chief Financial Officer, effective October 5, 2026, as the ...

Brings 15 years of pharma launch, health system, and direct-to-patient engagement experience as Achieve prepares for potential commercialization of cytisinicline. SEATTLE and VANC ...

Financial services leader joins Achieve to oversee the digital personal finance company's credit policy, modeling and risk management frameworks This strategic addition strengthens Achieve as it ...

"I'm honored to step into the role of Chief Executive Officer at such an important time." (CEO, President & Director Andrew Goldberg) Goldberg said Achieve is developing cytisinicline for "cessation ...

SAN MATEO, Calif., Sept. 29, 2025 /PRNewswire/ -- Achieve, the leader in digital personal finance, has promoted Jason Yee to the role of Chief Financial Officer. Yee, who has served as Executive Vice ...

Affiliate links for the products on this page are from partners that compensate us (see our advertiser disclosure with our list of partners for more details). However, our opinions are our own. See ...

Achieve Life Sciences is working to commercialize the smoking cessation drug Cytisinicline, which has shown promising results in clinical trials. The drug has a superior safety profile compared to ...

Achieve is a digital personal finance company founded in 2002 and based in San Mateo, California. Unlike traditional debt relief companies, Achieve offers a more comprehensive suite of tools, ...

Achieve Life Sciences (ACHV) is advancing cytisinicline, its sole product candidate, targeting FDA approval for nicotine dependence by June 2026. Cytisinicline's strong Phase 3 results and potential ...

The stock options and RSU awards are subject to the terms and conditions of the 2024 Equity Inducement Plan, as well as the ...